Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease

Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease

Mutations in the glucocerebrosidase (GBA) gene have been implicated in increased formation of Lewy bodies (LBs) in Parkinson's disease (PD). We found GBA mutation status not to be significantly associated with the density of cortical LBs, after adjusting for sex, age at death, duration of PD an...

Full description

Bibliographic Details
Main Authors:	Parkkinen, L, Neumann, J, O'Sullivan, S, Holton, J, Revesz, T, Hardy, J, Lees, A
Format:	Journal article
Published:	Elsevier 2011

Similar Items

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
by: Neumann, J, et al.
Published: (2009)

Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson's disease
by: O'Sullivan, S, et al.
Published: (2011)

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
by: Compta, Y, et al.
Published: (2011)

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders”
by: Parkkinen, L, et al.
Published: (2008)

Does levodopa accelerate the pathologic process in Parkinson disease brain?
by: Parkkinen, L, et al.
Published: (2011)

A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene
by: Jussi O. T. Sipilä, et al.
Published: (2023-04-01)

Lewy body-like inclusions in human midbrain organoids carrying glucocerebrosidase and α-synuclein mutations
by: Jo, Junghyun, et al.
Published: (2022)

The significance of α-Synuclein, Amyloid-β and Tau pathologies in Parkinson's disease progression and related dementia
by: Compta, Y, et al.
Published: (2013)

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies
by: L. Parnetti, et al.
Published: (2009-06-01)

Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson's disease.
by: Anjali Gera, et al.
Published: (2020-01-01)

Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
by: Diana A. Olszewska, et al.
Published: (2020-06-01)

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
by: Wei Zheng, et al.
Published: (2022-03-01)

Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
by: Cheryl E. G. Leyns, et al.
Published: (2023-05-01)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
by: Altay, MF, et al.
Published: (2022)

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
by: Zarranz, J, et al.
Published: (2004)

Glucocerebrosidase and its relevance to Parkinson disease
by: Jenny Do, et al.
Published: (2019-08-01)

Parkinsonisms and Glucocerebrosidase Deficiency: A Comprehensive Review for Molecular and Cellular Mechanism of Glucocerebrosidase Deficiency
by: Emilia M. Gatto, et al.
Published: (2019-02-01)

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
by: Roy N. Alcalay, et al.
Published: (2020-10-01)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
by: Melek Firat Altay, et al.
Published: (2022-11-01)

Glucocerebrosidase involvement in Parkinson Disease and other Synucleinopathies
by: Maria Rosario Almeida
Published: (2012-04-01)

Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
by: Melek Firat Altay, et al.
Published: (2023-12-01)

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
by: Orme, T, et al.
Published: (2020)

Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
by: Fabian J. David, et al.
Published: (2021-09-01)

Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
by: Tatiana Orme, et al.
Published: (2020-01-01)

Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life
by: Ruwei Ou, et al.
Published: (2023-11-01)

Gene Expression of Lysosomal Membrane Proteins in Parkinson Disease, Associated with Mutations in the Glucocerebrosidase Gene (GBA)
by: Tatiana S. Usenko, et al.
Published: (2020-06-01)

Glucocerebrosidase gene mutations associated with Parkinson's disease: a meta-analysis in a Chinese population.
by: Jia Chen, et al.
Published: (2014-01-01)

Glucocerebrosidase L444P mutation confers genetic risk for Parkinson’s disease in central China
by: Wang Youpei, et al.
Published: (2012-12-01)

Author Correction: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
by: Melek Firat Altay, et al.
Published: (2024-01-01)

Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria
by: Andrés D. Klein, et al.
Published: (2023-10-01)

Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies
by: Tu, Haitao, et al.
Published: (2022)

Increased expression of pathological markers in Parkinson’s disease dementia post-mortem brains compared to dementia with Lewy bodies
by: Haitao Tu, et al.
Published: (2022-01-01)

Patients’ experiences of Parkinson’s disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson’s disease
by: N. Bonner, et al.
Published: (2020-08-01)

Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases
by: Guerreiro, R, et al.
Published: (2015)

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
by: Micol Avenali, et al.
Published: (2020-04-01)

Did α-Synuclein and Glucocerebrosidase Coevolve? Implications for Parkinson's Disease.
by: James M Gruschus
Published: (2015-01-01)

Testing an aetiological model of visual hallucinations in Parkinson's disease
by: Gallagher, D, et al.
Published: (2011)

Axonal degeneration in the anterior insular cortex is associated with Alzheimer’s co-pathology in Parkinson’s disease and dementia with Lewy bodies
by: Yasmine Y. Fathy, et al.
Published: (2022-12-01)

The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”
by: Mehrdad Mozafar, et al.
Published: (2023-01-01)

Chaperoning glucocerebrosidase: a therapeutic strategy for both Gaucher disease and Parkinsonism
by: Benjamin McMahon, et al.
Published: (2016-01-01)